Early-treatment cerebral blood flow change as a predictive biomarker of antidepressant treatment response: evidence from the EMBARC clinical trial.
Dang Y, Lu B, Vanderwal T, Castellanos F, Yan C. Early-treatment cerebral blood flow change as a predictive biomarker of antidepressant treatment response: evidence from the EMBARC clinical trial. Psychological Medicine 2024, 54: 1-10. PMID: 38720516, DOI: 10.1017/s0033291724001156.Peer-Reviewed Original ResearchMajor depressive disorderBrain regionsTreatment of Major Depressive DisorderHamilton Depression Rating Scale scoresBiomarkers of antidepressant treatment responseCerebral blood flowBiosignatures of Antidepressant ResponseDepression Rating Scale scoresSerotonin reuptake inhibitor treatmentAntidepressant treatment responseResponse to antidepressantsTreatment responseRating Scale scoresBiomarkers of treatment responseAssociated with increased cerebral perfusionEstablishing ModeratorsAntidepressant responseAntidepressant effectsDepressive disorderTemporal cortexNeural biomarkersPostcentral regionsCerebral blood flow changesWhole-brainDisabling illness